-

63rd ASH Annual Meeting & Exposition

American Society of Hematology (ASH) 63rd annual meeting with both in-person and virtual participation at the Georgia World Congress Center in Atlanta, Georgia. ASH Annual Meeting & Exposition is the largest event in malignant and non-malignant hematology.

The agenda for Oncopeptides posters.

Saturday, December 11, 2021, 5:30-07:30 PM EST

  • Session name: 605. Molecular Pharmacology and Drug Resistance: Lymphoid Neoplasms: Poster I
  • Single Cell RNA Sequencing Identifies Potential Molecular Indicators of Response to Melflufen in Multiple Myeloma
    • Lead Author: Philipp Sergeev
    • Publication Number: 1194

Sunday, December 12, 2021, 6:00-8:00 PM EST

  • Session name: 653. Myeloma and Plasma Cell Dyscrasias: Clinical-Prospective Therapeutic Trials: Poster II
  • Melflufen/Dexamethasone Compared With Pomalidomide/Dexamethasone in Patients With Relapsed/Refractory Multiple Myeloma – Age Subgroup Analysis of Older Patients
    • Lead Author: Marivi Mateos
    • Publication Number: 2741
  • Melflufen/Dexamethasone Compared With Pomalidomide/Dexamethasone in Patients With Relapsed/Refractory Multiple Myeloma – Safety and Tolerability Analysis
    • Lead Author: Paul M Richardson
    • Publication Number: 2732

Upcoming events

Silent Period

-

Silent Period

-

Year-end report 2022

08:00 CET